Search - tctmd.com

Displaying 21 - 40 of 67

Sort: Relevancy | Date

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Daily News

Smoking Linked With Worse Outcomes in Hospitalized COVID-19 Patients

Michael O'Riordan

July 29, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

More Evidence Links Breast Arterial Calcification and CVD Risk

News Daily News

Even Less-Severe COVID-19 Can Have Long-term CV Effects

Caitlin E. Cox

February 10, 2022

News Daily News

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

Michael O'Riordan

October 28, 2021

News Daily News

Marijuana Ups Bleeding, CVA Risks in PCI Patients: Registry Data

Caitlin E. Cox

August 16, 2021

News Conference News ACC 2021

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

L.A. McKeown

May 21, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Nationwide Data Shed Light on Timing, Predictors of Acute MI in Pregnancy

Caitlin E. Cox

November 03, 2020

News Daily News

Influenza and Acute CV Events Can Go Hand in Hand

Caitlin E. Cox

August 25, 2020

News Daily News

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Michael O'Riordan

August 11, 2020

News Daily News

COVID-19 Clots Spur Both Arterial, Venous Events in Hospitalized Patients

Caitlin E. Cox

July 24, 2020

News Daily News

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Michael O'Riordan

May 04, 2020

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Conference News ESC 2019

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

Caitlin E. Cox

September 06, 2019

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

News Daily News

Ischemic Events Worsen Long-term Cognitive Decline

Yael L. Maxwell

June 18, 2019

News Conference News EAS 2019

Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality

Michael O'Riordan

June 05, 2019

News Daily News

Bariatric Surgery Linked to Survival Advantage After MI and CVA

Michael O'Riordan

May 13, 2019

Advertisement

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

Smoking Linked With Worse Outcomes in Hospitalized COVID-19 Patients

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

More Evidence Links Breast Arterial Calcification and CVD Risk

Even Less-Severe COVID-19 Can Have Long-term CV Effects

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

Marijuana Ups Bleeding, CVA Risks in PCI Patients: Registry Data

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Nationwide Data Shed Light on Timing, Predictors of Acute MI in Pregnancy

Influenza and Acute CV Events Can Go Hand in Hand

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

COVID-19 Clots Spur Both Arterial, Venous Events in Hospitalized Patients

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Recurrent Events Common Among Young Patients With CAD

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Ischemic Events Worsen Long-term Cognitive Decline

Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality

Bariatric Surgery Linked to Survival Advantage After MI and CVA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content